← FDA DRUG APPROVALS

FDA ANDA · ANDA074404

ATENOLOL AND CHLORTHALIDONE

Sponsor: NOSTRUM LABS

APPLICATION
ANDA074404
TYPE
ANDA
ORIGINAL APPROVAL
1998-05-14
LATEST ACTION
2000-06-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ATENOLOL AND CHLORTHALIDONEDiscontinued
ATENOLOL 50MG, CHLORTHALIDONE 25MG · TABLET · ORAL
ATENOLOL AND CHLORTHALIDONEDiscontinued
ATENOLOL 100MG, CHLORTHALIDONE 25MG · TABLET · ORAL

Approval history

2000-06-07Labeling · Supplement 1AP
1998-05-14Original — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →